MADISON, Wis., Nov. 20, 2024 /CNW/ -- BioVaxys Technology Corp. (CNSX:BIOV.CN) (FRA:5LB) (OTC-BB:BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are pleased to jointly announce that SpayVac for Wildlife, Inc.'s Madison, Wisconsin laboratory and production facility is now fully able to supply its cutting-edge contraceptive vaccines, including its well-established pZP vaccine ("SpayVac®") and its newest GnRH vaccine for commercial aquaculture and other species.
Read more at newswire.caBIOVAXYS PARTNER SPAYVAC FOR WILDLIFE, INC., SCALES-UP VACCINE PRODUCTION CAPACITY
Newswire.ca - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Technology%20abstract%20by%20TU%20IS%20via%20iStock.jpg)
